Dataset Preview
The full dataset viewer is not available (click to read why). Only showing a preview of the rows.
Could not read the parquet files: Parquet magic bytes not found in footer. Either the file is corrupted or this is not a parquet file.
Error code: FileSystemError
Need help to make the dataset viewer work? Make sure to review how to configure the dataset viewer, and open a discussion for direct support.
release_id string | moiety_id string | preferred_name string | normalization_status string | resolution_class string | unii string | gsrs_uuid string | linking_id string | substance_class string | gsrs_source_version string |
|---|---|---|---|---|---|---|---|---|---|
development | gsrs:003N66TS6T | RASAGILINE | explicit_gsrs_relationship | explicit_active_moiety | 003N66TS6T | c23f1de7-380d-4dcc-9bcd-4e7a8084b243 | 003N66TS6T | reference | 2026-07-06 |
development | gsrs:004F72P8F4 | BETHANECHOL | explicit_gsrs_relationship | explicit_active_moiety | 004F72P8F4 | 6ac026de-bfa5-460a-b3f8-44099dc43cc7 | 004F72P8F4 | reference | 2026-07-06 |
development | gsrs:005990WHZZ | DEOXYCHOLIC ACID | explicit_gsrs_relationship | explicit_active_moiety | 005990WHZZ | 26792403-f64c-44d2-a21a-e8d124b34f19 | 005990WHZZ | reference | 2026-07-06 |
development | gsrs:00Y6A5AJU6 | SOFPIRONIUM | explicit_gsrs_relationship | explicit_active_moiety | 00Y6A5AJU6 | 33cb43ad-b54b-4a6f-8e15-01050f951bb7 | 00Y6A5AJU6 | reference | 2026-07-06 |
development | gsrs:013TE6E4WV | LEDIPASVIR | explicit_gsrs_relationship | explicit_active_moiety | 013TE6E4WV | 5cde5c72-21ee-4f47-9e35-2e4cab38ed8c | 013TE6E4WV | reference | 2026-07-06 |
development | gsrs:0199MV609F | GADOTERIDOL | explicit_gsrs_relationship | explicit_active_moiety | 0199MV609F | 4d65a162-efdc-442e-9322-dc728ef43bab | 0199MV609F | reference | 2026-07-06 |
development | gsrs:01K63SUP8D | FLUOXETINE | explicit_gsrs_relationship | explicit_active_moiety | 01K63SUP8D | 288a962b-7ef1-4a4e-9cfe-0eb1bb3ce661 | 01K63SUP8D | reference | 2026-07-06 |
development | gsrs:01MI4Q9DI3 | Pilocarpine | explicit_gsrs_relationship | explicit_active_moiety | 01MI4Q9DI3 | 3ccc705e-3337-4708-b6de-7541644a3560 | 01MI4Q9DI3 | reference | 2026-07-06 |
development | gsrs:01T23W89FR | THIAMYLAL | explicit_gsrs_relationship | explicit_active_moiety | 01T23W89FR | 8f29865f-182e-45ca-a2e3-2cf1fc55b9ec | 01T23W89FR | reference | 2026-07-06 |
development | gsrs:01YAE03M7J | BETA CAROTENE | explicit_gsrs_relationship | explicit_active_moiety | 01YAE03M7J | bea94a27-7fc2-443d-acde-0d647279df98 | 01YAE03M7J | reference | 2026-07-06 |
development | gsrs:01ZG3TPX31 | BUPROPION | explicit_gsrs_relationship | explicit_active_moiety | 01ZG3TPX31 | 3d473a96-77e0-4eeb-8cdc-822fde105b5c | 01ZG3TPX31 | reference | 2026-07-06 |
development | gsrs:022461SR75 | AZFICEL-T | explicit_gsrs_relationship | explicit_active_moiety | 022461SR75 | 7fd93703-9bd0-4ad8-a46a-4bca176cfd9b | 022461SR75 | reference | 2026-07-06 |
development | gsrs:023C2WHX2V | TROMETHAMINE | explicit_gsrs_relationship | explicit_active_moiety | 023C2WHX2V | 9e6546dc-5501-4aa2-bc96-9c7163f78b58 | 023C2WHX2V | reference | 2026-07-06 |
development | gsrs:025P9I542Y | CYANOCOBALAMIN CO-57 | explicit_gsrs_relationship | explicit_active_moiety | 025P9I542Y | 9c53b82a-8dce-41fd-a385-067fcf29179c | 025P9I542Y | reference | 2026-07-06 |
development | gsrs:028LZY775B | VILANTEROL | explicit_gsrs_relationship | explicit_active_moiety | 028LZY775B | c495eb65-9c32-49e1-85dd-e9ce4701bf15 | 028LZY775B | reference | 2026-07-06 |
development | gsrs:02OS7K758T | METHARBITAL | explicit_gsrs_relationship | explicit_active_moiety | 02OS7K758T | cf669a4b-92b3-4881-bea0-ff5e6fefde4d | 02OS7K758T | reference | 2026-07-06 |
development | gsrs:030PYR8953 | ROPINIROLE | explicit_gsrs_relationship | explicit_active_moiety | 030PYR8953 | 42309f06-bb6c-4965-90ab-debd7c516554 | 030PYR8953 | reference | 2026-07-06 |
development | gsrs:030Y90569U | NEBIVOLOL | explicit_gsrs_relationship | explicit_active_moiety | 030Y90569U | e933eb1a-38e7-4873-aea6-f2e21fdbf8b7 | 030Y90569U | reference | 2026-07-06 |
development | gsrs:033072U4MZ | GOLODIRSEN | explicit_gsrs_relationship | explicit_active_moiety | 033072U4MZ | e54505d8-4af5-43f6-95b4-f70effe0b457 | 033072U4MZ | reference | 2026-07-06 |
development | gsrs:033KF7V46H | TINIDAZOLE | explicit_gsrs_relationship | explicit_active_moiety | 033KF7V46H | 622f1ded-3453-4efe-8057-8842edd411ce | 033KF7V46H | reference | 2026-07-06 |
development | gsrs:038E5L962W | Lifitegrast | explicit_gsrs_relationship | explicit_active_moiety | 038E5L962W | 8fe3895f-2fd1-4a43-901c-4ba48e88d34e | 038E5L962W | reference | 2026-07-06 |
development | gsrs:039LU44I5M | Floxuridine | explicit_gsrs_relationship | explicit_active_moiety | 039LU44I5M | 32e71398-cbb8-4492-ba9b-0b92dd05f89e | 039LU44I5M | reference | 2026-07-06 |
development | gsrs:03KSI6WLXH | NALDEMEDINE | explicit_gsrs_relationship | explicit_active_moiety | 03KSI6WLXH | d1bf0180-7a9a-4277-8b31-4366b24cc7ff | 03KSI6WLXH | reference | 2026-07-06 |
development | gsrs:03V657ZD3V | METHACHOLINE | explicit_gsrs_relationship | explicit_active_moiety | 03V657ZD3V | 5d59bc55-62f0-4249-9c0c-4c0e42a43cf8 | 03V657ZD3V | reference | 2026-07-06 |
development | gsrs:04079A1RDZ | CYTARABINE | explicit_gsrs_relationship | explicit_active_moiety | 04079A1RDZ | 2b258dc9-0ac3-44df-bc57-7712751e5cbe | 04079A1RDZ | reference | 2026-07-06 |
development | gsrs:0462Z4S4OZ | OBETICHOLIC ACID | explicit_gsrs_relationship | explicit_active_moiety | 0462Z4S4OZ | 27958e0b-b3b1-40ef-98eb-75a25fd085b2 | 0462Z4S4OZ | reference | 2026-07-06 |
development | gsrs:046O35D44R | PRILOCAINE | explicit_gsrs_relationship | explicit_active_moiety | 046O35D44R | 05a7ed20-b6db-4c6c-a529-a02daa7e1981 | 046O35D44R | reference | 2026-07-06 |
development | gsrs:0475EA27Q3 | BENZQUINAMIDE | explicit_gsrs_relationship | explicit_active_moiety | 0475EA27Q3 | 428fabc1-9a6d-4269-9e60-8b8c922f34f7 | 0475EA27Q3 | reference | 2026-07-06 |
development | gsrs:048L81261F | Dexrazoxane | explicit_gsrs_relationship | explicit_active_moiety | 048L81261F | 06f3b671-bbc9-4679-92df-7c9774e19464 | 048L81261F | reference | 2026-07-06 |
development | gsrs:04Q9AIZ7NO | PEMETREXED | explicit_gsrs_relationship | explicit_active_moiety | 04Q9AIZ7NO | 088acdd0-363d-4688-8342-3f1a7f6c9c50 | 04Q9AIZ7NO | reference | 2026-07-06 |
development | gsrs:04XPW8C0FL | APROTININ | explicit_gsrs_relationship | explicit_active_moiety | 04XPW8C0FL | a0075182-357d-4189-ae60-472b911ccf5f | 04XPW8C0FL | reference | 2026-07-06 |
development | gsrs:04ZR38536J | OXALIPLATIN | explicit_gsrs_relationship | explicit_active_moiety | 04ZR38536J | be894835-9697-4cde-9b05-6bd80242333c | 04ZR38536J | reference | 2026-07-06 |
development | gsrs:0570F37359 | VOXILAPREVIR | explicit_gsrs_relationship | explicit_active_moiety | 0570F37359 | a9dbc1e8-053d-4be8-a3ee-3bea0ecf4d60 | 0570F37359 | reference | 2026-07-06 |
development | gsrs:0578K3ELIO | ACECLIDINE | explicit_gsrs_relationship | explicit_active_moiety | 0578K3ELIO | 8ef73124-06ae-4b55-bfd5-528c5adb5784 | 0578K3ELIO | reference | 2026-07-06 |
development | gsrs:059QF0KO0R | WATER | explicit_gsrs_relationship | explicit_active_moiety | 059QF0KO0R | 782a70f7-bf7f-473f-b7bb-a170a693ad53 | 059QF0KO0R | reference | 2026-07-06 |
development | gsrs:05V02F2KDG | ROSIGLITAZONE | explicit_gsrs_relationship | explicit_active_moiety | 05V02F2KDG | e754d738-7fe3-4a9e-8ecd-29e16e14a5ec | 05V02F2KDG | reference | 2026-07-06 |
development | gsrs:0619F35CGV | TETRACAINE | explicit_gsrs_relationship | explicit_active_moiety | 0619F35CGV | b78fc0df-04de-4eaf-b1ea-c76e2f4c483c | 0619F35CGV | reference | 2026-07-06 |
development | gsrs:068X84E056 | PRAMOXINE | explicit_gsrs_relationship | explicit_active_moiety | 068X84E056 | f8db396e-09ac-434d-85a1-53b22dd6af4f | 068X84E056 | reference | 2026-07-06 |
development | gsrs:06A33308KH | STRONTIUM CATION SR-89 | explicit_gsrs_relationship | explicit_active_moiety | 06A33308KH | 5a5d57f5-cfe8-4f9a-aa5f-7637af9a2d36 | 06A33308KH | reference | 2026-07-06 |
development | gsrs:06LU7C9H1V | LIOTHYRONINE | explicit_gsrs_relationship | explicit_active_moiety | 06LU7C9H1V | 9a24f30e-4f70-4410-a94d-e38b9dff7f61 | 06LU7C9H1V | reference | 2026-07-06 |
development | gsrs:076WHW89TW | FOLLITROPIN | explicit_gsrs_relationship | explicit_active_moiety | 076WHW89TW | 0576638a-2949-48ae-a4c6-5ed05d766182 | 076WHW89TW | reference | 2026-07-06 |
development | gsrs:07730V90L6 | TALIMOGENE LAHERPAREPVEC | explicit_gsrs_relationship | explicit_active_moiety | 07730V90L6 | ed347b9a-697a-4a17-8b4d-f67ba16e1980 | 07730V90L6 | reference | 2026-07-06 |
development | gsrs:07896928ZC | ERAVACYCLINE | explicit_gsrs_relationship | explicit_active_moiety | 07896928ZC | 2c7e460c-95cd-4ddd-af7c-7cc1d8f42067 | 07896928ZC | reference | 2026-07-06 |
development | gsrs:078A24Q30O | DYCLONINE | explicit_gsrs_relationship | explicit_active_moiety | 078A24Q30O | 2682ead5-4cf1-4bfe-b5a5-260ec16dc345 | 078A24Q30O | reference | 2026-07-06 |
development | gsrs:081L192FO9 | Suvorexant | explicit_gsrs_relationship | explicit_active_moiety | 081L192FO9 | 019d068a-4f64-4b06-acdf-81a5bb6d730e | 081L192FO9 | reference | 2026-07-06 |
development | gsrs:089658A12D | GUSELKUMAB | explicit_gsrs_relationship | explicit_active_moiety | 089658A12D | b4e60e76-e376-4e5f-ac4f-4f071a93ecf2 | 089658A12D | reference | 2026-07-06 |
development | gsrs:08GY9K1EUO | RASBURICASE | explicit_gsrs_relationship | explicit_active_moiety | 08GY9K1EUO | fae859c4-9187-4043-ba87-8171064fe0bd | 08GY9K1EUO | reference | 2026-07-06 |
development | gsrs:08O3FQ4UNP | REPOTRECTINIB | explicit_gsrs_relationship | explicit_active_moiety | 08O3FQ4UNP | 405800dd-5722-4a29-bdbf-3ab5c1544677 | 08O3FQ4UNP | reference | 2026-07-06 |
development | gsrs:08W5N2C97Q | ALPELISIB | explicit_gsrs_relationship | explicit_active_moiety | 08W5N2C97Q | 72028cb9-fb72-48e6-acd3-b52dbc70030f | 08W5N2C97Q | reference | 2026-07-06 |
development | gsrs:090IP5RV8F | OMADACYCLINE | explicit_gsrs_relationship | explicit_active_moiety | 090IP5RV8F | e830b957-4b9e-4100-b413-5791e6689dfb | 090IP5RV8F | reference | 2026-07-06 |
development | gsrs:094ZI81Y45 | TAMOXIFEN | explicit_gsrs_relationship | explicit_active_moiety | 094ZI81Y45 | 8986565b-08ad-42cb-ba24-8d7fbe9de803 | 094ZI81Y45 | reference | 2026-07-06 |
development | gsrs:09ERP08I3W | LESINURAD | explicit_gsrs_relationship | explicit_active_moiety | 09ERP08I3W | 0d793e69-0162-41dd-bca1-1c3b809b81ac | 09ERP08I3W | reference | 2026-07-06 |
development | gsrs:09G4I6V86Q | IODIDE ION | explicit_gsrs_relationship | explicit_active_moiety | 09G4I6V86Q | 82b2dd0f-820d-4e49-be66-9e63e8411f03 | 09G4I6V86Q | reference | 2026-07-06 |
development | gsrs:09Q5UV3747 | SEGESTERONE | explicit_gsrs_relationship | explicit_active_moiety | 09Q5UV3747 | 44614859-6474-4e85-afc8-754f84ef2542 | 09Q5UV3747 | reference | 2026-07-06 |
development | gsrs:0A09IUW5TP | Prucalopride | explicit_gsrs_relationship | explicit_active_moiety | 0A09IUW5TP | 4d711dc4-fa38-4f57-aed9-2ee85f9b7995 | 0A09IUW5TP | reference | 2026-07-06 |
development | gsrs:0AWH8BFG9A | POLIDOCANOL | explicit_gsrs_relationship | explicit_active_moiety | 0AWH8BFG9A | 24dedbbe-b501-4684-bd64-2713bac78545 | 0AWH8BFG9A | reference | 2026-07-06 |
development | gsrs:0B535E0BN0 | NEDOCROMIL | explicit_gsrs_relationship | explicit_active_moiety | 0B535E0BN0 | e85dd767-149b-4ffe-83ab-c63eeeae3b39 | 0B535E0BN0 | reference | 2026-07-06 |
development | gsrs:0C50HW4FO1 | ETRAVIRINE | explicit_gsrs_relationship | explicit_active_moiety | 0C50HW4FO1 | 7b333585-3d0f-451d-8862-93def68d0d29 | 0C50HW4FO1 | reference | 2026-07-06 |
development | gsrs:0C94V6X681 | BUCLIZINE | explicit_gsrs_relationship | explicit_active_moiety | 0C94V6X681 | e694a1f5-75a1-4ec0-b262-8dccca436b81 | 0C94V6X681 | reference | 2026-07-06 |
development | gsrs:0CA0VSF91Y | DEURUXOLITINIB | explicit_gsrs_relationship | explicit_active_moiety | 0CA0VSF91Y | 9df9e1b5-7d35-4e65-aa25-75ec3f998993 | 0CA0VSF91Y | reference | 2026-07-06 |
development | gsrs:0CD5FD6S2M | FLUOCINOLONE ACETONIDE | explicit_gsrs_relationship | explicit_active_moiety | 0CD5FD6S2M | c67b2ccf-d599-4d54-85a0-f7a83bb108b8 | 0CD5FD6S2M | reference | 2026-07-06 |
development | gsrs:0CPP32S55X | DIMERCAPROL | explicit_gsrs_relationship | explicit_active_moiety | 0CPP32S55X | ddd33fa6-e6ae-43fe-99fb-a1acabd65d23 | 0CPP32S55X | reference | 2026-07-06 |
development | gsrs:0D3Q044KCA | Galantamine | explicit_gsrs_relationship | explicit_active_moiety | 0D3Q044KCA | c3df8491-faa2-4820-b563-dbe61ca71d75 | 0D3Q044KCA | reference | 2026-07-06 |
development | gsrs:0DHU5B8D6V | CITALOPRAM | explicit_gsrs_relationship | explicit_active_moiety | 0DHU5B8D6V | 87ac0121-f698-4b47-b330-7a60e77925f3 | 0DHU5B8D6V | reference | 2026-07-06 |
development | gsrs:0EB439235F | TIOTROPIUM | explicit_gsrs_relationship | explicit_active_moiety | 0EB439235F | f5dfecfa-5d14-4ebd-a38f-9fa840389cdd | 0EB439235F | reference | 2026-07-06 |
development | gsrs:0F350BVT6S | ECHOTHIOPHATE | explicit_gsrs_relationship | explicit_active_moiety | 0F350BVT6S | 60dbfb64-6861-4892-abec-ffcc9797a22f | 0F350BVT6S | reference | 2026-07-06 |
development | gsrs:0F65R8P09N | GOSERELIN | explicit_gsrs_relationship | explicit_active_moiety | 0F65R8P09N | 6a35e5fe-7673-4c71-bc2c-216173f60a81 | 0F65R8P09N | reference | 2026-07-06 |
development | gsrs:0FRP6G56LD | BIPERIDEN | explicit_gsrs_relationship | explicit_active_moiety | 0FRP6G56LD | 5eb75731-f224-41b7-8733-71993d3d6d01 | 0FRP6G56LD | reference | 2026-07-06 |
development | gsrs:0G389FZZ9M | LEVOCARNITINE | explicit_gsrs_relationship | explicit_active_moiety | 0G389FZZ9M | 523e21ff-f2d9-4fbb-9842-1e91ad778ba6 | 0G389FZZ9M | reference | 2026-07-06 |
development | gsrs:0G3C18OH4D | SULFOXONE | explicit_gsrs_relationship | explicit_active_moiety | 0G3C18OH4D | 675c987d-fbf5-4aaa-966d-2bb364031846 | 0G3C18OH4D | reference | 2026-07-06 |
development | gsrs:0G3DE8943Y | LANREOTIDE | explicit_gsrs_relationship | explicit_active_moiety | 0G3DE8943Y | d4ef957c-64a8-4e60-bfbe-4a9caa449279 | 0G3DE8943Y | reference | 2026-07-06 |
development | gsrs:0G76K8X6C0 | METHSUXIMIDE | explicit_gsrs_relationship | explicit_active_moiety | 0G76K8X6C0 | c922b85d-81f0-4fe7-bc69-133f381c8df0 | 0G76K8X6C0 | reference | 2026-07-06 |
development | gsrs:0G9LGB5O2W | Mavorixafor | explicit_gsrs_relationship | explicit_active_moiety | 0G9LGB5O2W | c999a93c-2ec5-48f4-99b1-96554b60896b | 0G9LGB5O2W | reference | 2026-07-06 |
development | gsrs:0GEI24LG0J | CHENODIOL | explicit_gsrs_relationship | explicit_active_moiety | 0GEI24LG0J | 75e0299d-d7e5-4e08-b5cf-03553f99919a | 0GEI24LG0J | reference | 2026-07-06 |
development | gsrs:0GRZ0F5XJ6 | EPLONTERSEN | explicit_gsrs_relationship | explicit_active_moiety | 0GRZ0F5XJ6 | dc94a266-4ad7-4434-8c01-348ea80fd561 | 0GRZ0F5XJ6 | reference | 2026-07-06 |
development | gsrs:0H73WJJ391 | TOPIRAMATE | explicit_gsrs_relationship | explicit_active_moiety | 0H73WJJ391 | f413079b-3bf0-415f-a3ad-c0fc03b58864 | 0H73WJJ391 | reference | 2026-07-06 |
development | gsrs:0I55128JYK | THEOPHYLLINE ANHYDROUS | explicit_gsrs_relationship | explicit_active_moiety | 0I55128JYK | 76c4b680-31ca-4f46-95c2-5ba927dc573a | 0I55128JYK | reference | 2026-07-06 |
development | gsrs:0IEO0F56LV | INOTERSEN | explicit_gsrs_relationship | explicit_active_moiety | 0IEO0F56LV | 8acdfbb5-9ba8-457f-b41d-0375493a2e7d | 0IEO0F56LV | reference | 2026-07-06 |
development | gsrs:0J48LPH2TH | HYDROCHLOROTHIAZIDE | explicit_gsrs_relationship | explicit_active_moiety | 0J48LPH2TH | 30c841c3-7422-44ca-948a-9bfbe9f0d977 | 0J48LPH2TH | reference | 2026-07-06 |
development | gsrs:0J8L4V3F81 | SULFAPHENAZOLE | explicit_gsrs_relationship | explicit_active_moiety | 0J8L4V3F81 | 77620eb8-d8eb-4b0c-a9ba-de0f5943ae3a | 0J8L4V3F81 | reference | 2026-07-06 |
development | gsrs:0J8RN2W0HK | TRIFAROTENE | explicit_gsrs_relationship | explicit_active_moiety | 0J8RN2W0HK | 3600a8d9-aa6c-468e-8c31-728ac7bc9501 | 0J8RN2W0HK | reference | 2026-07-06 |
development | gsrs:0K47UL67F2 | CARVEDILOL | explicit_gsrs_relationship | explicit_active_moiety | 0K47UL67F2 | 56bb4f60-d18b-4bcf-b2cf-4825b102a5c3 | 0K47UL67F2 | reference | 2026-07-06 |
development | gsrs:0K5743G68X | LEMBOREXANT | explicit_gsrs_relationship | explicit_active_moiety | 0K5743G68X | 555c9b22-4fc7-4d1b-8ab1-9d0d50141aa5 | 0K5743G68X | reference | 2026-07-06 |
development | gsrs:0KJ2VE664U | TERCONAZOLE | explicit_gsrs_relationship | explicit_active_moiety | 0KJ2VE664U | 16998fca-d01a-4fd5-8cad-ee78ebcbdf9c | 0KJ2VE664U | reference | 2026-07-06 |
development | gsrs:0L1F17908Q | CILTACABTAGENE AUTOLEUCEL | explicit_gsrs_relationship | explicit_active_moiety | 0L1F17908Q | c7e105a7-1b2e-59e7-eb1e-ae8c610d7598 | 0L1F17908Q | reference | 2026-07-06 |
development | gsrs:0M3S43XK27 | BENZPHETAMINE | explicit_gsrs_relationship | explicit_active_moiety | 0M3S43XK27 | f941e094-5116-4b84-9258-fcfbfca81c57 | 0M3S43XK27 | reference | 2026-07-06 |
development | gsrs:0N7609K889 | SULFADIAZINE | explicit_gsrs_relationship | explicit_active_moiety | 0N7609K889 | b6b227c0-aeb0-45ab-bf3f-465af25ec64b | 0N7609K889 | reference | 2026-07-06 |
development | gsrs:0NJ98Y462X | CONIVAPTAN | explicit_gsrs_relationship | explicit_active_moiety | 0NJ98Y462X | 394b44f0-c4f9-4595-afa2-16e61f809e5e | 0NJ98Y462X | reference | 2026-07-06 |
development | gsrs:0O54ZQ14I9 | AMINOGLUTETHIMIDE | explicit_gsrs_relationship | explicit_active_moiety | 0O54ZQ14I9 | dd76e8ed-7351-489d-b817-e76ba31acc5c | 0O54ZQ14I9 | reference | 2026-07-06 |
development | gsrs:0O72R8RF8A | AMINO ACIDS, SOURCE UNSPECIFIED | explicit_gsrs_relationship | explicit_active_moiety | 0O72R8RF8A | 5cec2f3f-d9ee-46c9-a590-adc22c0b9e38 | 0O72R8RF8A | reference | 2026-07-06 |
development | gsrs:0O977R722D | OXAMNIQUINE | explicit_gsrs_relationship | explicit_active_moiety | 0O977R722D | 2e1e1667-715b-4912-9762-d54d22cea5c0 | 0O977R722D | reference | 2026-07-06 |
development | gsrs:0P6C6ZOP5U | Roflumilast | explicit_gsrs_relationship | explicit_active_moiety | 0P6C6ZOP5U | 7ccc749c-db88-461b-9e01-857e6fc8d6f8 | 0P6C6ZOP5U | reference | 2026-07-06 |
development | gsrs:0P6NLP6806 | LEVAMLODIPINE | explicit_gsrs_relationship | explicit_active_moiety | 0P6NLP6806 | 1abae413-0adf-43d0-8222-88e48365e8fb | 0P6NLP6806 | reference | 2026-07-06 |
development | gsrs:0P94UQE6SY | COAGULATION FACTOR X HUMAN | explicit_gsrs_relationship | explicit_active_moiety | 0P94UQE6SY | 2cd8c9c6-02e8-4385-8948-f21884e0d490 | 0P94UQE6SY | reference | 2026-07-06 |
development | gsrs:0Q771797PH | BUTOCONAZOLE | explicit_gsrs_relationship | explicit_active_moiety | 0Q771797PH | 1888da80-ae4c-418e-bab0-6f1e96ed7d7b | 0Q771797PH | reference | 2026-07-06 |
development | gsrs:0QTW8Z7MCR | ROFECOXIB | explicit_gsrs_relationship | explicit_active_moiety | 0QTW8Z7MCR | b8eac3a8-d0d8-43b8-865b-bd4eefa20ae7 | 0QTW8Z7MCR | reference | 2026-07-06 |
development | gsrs:0R4NLX88O4 | TALIGLUCERASE ALFA | explicit_gsrs_relationship | explicit_active_moiety | 0R4NLX88O4 | 57599ceb-4a90-4627-bc48-63168169e0d4 | 0R4NLX88O4 | reference | 2026-07-06 |
development | gsrs:0RH81L854J | Glutamine | explicit_gsrs_relationship | explicit_active_moiety | 0RH81L854J | bfec7618-6a91-4bd4-8e75-13a8942072e8 | 0RH81L854J | reference | 2026-07-06 |
development | gsrs:0RK7M7IABE | METHYLNALTREXONE | explicit_gsrs_relationship | explicit_active_moiety | 0RK7M7IABE | 56fad0f7-ef7c-41e8-8b4c-9760b1071105 | 0RK7M7IABE | reference | 2026-07-06 |
development | gsrs:0RLU3VTK5M | SONIDEGIB | explicit_gsrs_relationship | explicit_active_moiety | 0RLU3VTK5M | 1728e0a3-9eab-454e-a56a-838c3326e71d | 0RLU3VTK5M | reference | 2026-07-06 |
End of preview.
No dataset card yet
- Downloads last month
- 343